Work

A phase II clinical trial of HDACi (vorinostat) and AI therapy in breast cancer with molecular imaging correlates.

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.15_suppl.556

Authors: Hannah M. Linden, Brenda F. Kurland, Jeanne Link, Alena Novakova, Xiaoyu Chai, Jennifer M. Specht, Vijayakrishna K. Gadi, Julie Gralow, Erin K Schubert, Lanell Peterson, Janet F. Eary, Andrew Shields, David A. Mankoff, Kenneth A. Krohn

Institutions: University of Washington, UPMC Hillman Cancer Center, Fred Hutch Cancer Center, Seattle Cancer Care Alliance, University of Pennsylvania

Language: English

Topic: Histone Deacetylase Inhibitors Research

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2602931942

Cites:

Cited by: 3

Related to: 10